Doctolib Stock

doctolib.frHealthcareFounded: 2013

Doctolib is an online healthcare platform that allows its users to access health professionals as well as manage their appointments and health documents. This company was founded in 2013 by Stanislas Niox-Chateau, Jessy Bernal, Steve Rjeily, Ivan Schneider, Marc Laurent, and Olivier Occelli and is headquartered in Levallois-Perret, France.

Buy or sell Doctolib stock Learn more about Doctolib IPO

Overview Financings Valuation

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Doctolib.

Register Today

Doctolib investors also invested in these private companies

Scale AI, Celonis, DJI, SingleStore (MemSQL), Addepar, Cohesity, GoFundMe, Vectra AI, Circle, Vercel

General Atlantic

Chime, Klarna, Automation Anywhere, Back Market, Coalition, Airbnb, Ginkgo Bioworks, Gympass, Doctor on Demand, SquareSpace

Bpifrance

ContentSquare, Exotec, Vestiaire Collective, Doctolib, ManoMano

Eurazeo

MessageBird, ContentSquare, Vestiaire Collective, Qonto, Doctolib, ManoMano, Ankorstore, Aiven, PPRO

Kerala Ventures

Kernel Investissements

Team

Management Team

Stanislas Niox-Chateau

Co-Founder, Chief Executive Officer, Chairman & President

Philippe Vimard

Group Chief Operating Officer & Board Member

Jacques de la Bouillerie

Chief Operating Officer

Julien Meraud

Chief Strategy Officer & Chief Product Officer

Jessy Bernal

Co-Founder, Chief Technology Officer, Board Member & Solution Architect

Arthur Thirion

Chief Sales Officer & Managing Director

Agnès Bazin

Chief Development Officer

Matthieu Birach

Chief People Officer

Board Members

Antoine Freysz

Kerala Ventures

Ivan Schneider

Board Member

Philippe Botteri

Accel

Philippe Vimard

Board Member

Other companies like Doctolib in the Healthcare sector

Sector

Last Round Est. Valuation

$2.15B

Sector

Last Round Est. Valuation

$3.67B

Sector

Last Round Est. Valuation

$4.26B

Sector

Last Round Est. Valuation

$317.32MM

Sector

Sector

Last Round Est. Valuation

$1.59B

Biosplice Therapeutics

Sector

Mammoth Biosciences

Sector

Last Round Est. Valuation

$1.08B

Sector

Last Round Est. Valuation

$334.19MM

Frequently Asked Questions